Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Antifungal Gel Recalled
08/11/2022
A Class II recall has been issued for a prescription gel used to treat fungal skin infections.
A Class II recall has been issued for a prescription gel used to treat fungal skin infections.
A Class II recall has been...
08/11/2022
Pharmacy Learning Network
News
Nearly 9 in 10 Health-System Pharmacists Face High Risk for Burnout
08/09/2022
“Individual stress-reduction strategies…have a limited role in reducing burnout because they do not address burnout causes and contributors,” investigators said.
“Individual stress-reduction strategies…have a limited role in reducing burnout because they do not address burnout causes and contributors,” investigators said.
“Individual stress-reduction...
08/09/2022
Pharmacy Learning Network

Advertisement

News
Pharmacist-led Chronic Care Management Benefits Underserved Rural Patients
08/08/2022
At a rural, medically underserved family medicine clinic, a pharmacist-driven practice model significantly improved patient access to care within 6 months.
At a rural, medically underserved family medicine clinic, a pharmacist-driven practice model significantly improved patient access to care within 6 months.
At a rural, medically...
08/08/2022
Pharmacy Learning Network
News
Blood Pressure Drug Recalled
08/04/2022
Jubilant Cadista Pharmaceuticals is voluntarily recalling a prescription medication used to lower blood pressure in patients with hypertension.
Jubilant Cadista Pharmaceuticals is voluntarily recalling a prescription medication used to lower blood pressure in patients with hypertension.
Jubilant Cadista Pharmaceuticals...
08/04/2022
Pharmacy Learning Network
News
Proton Pump Inhibitor Recalled
08/04/2022
Prescription proton pump inhibitors are under a Class II recall for failing to meet dissolution specifications.
Prescription proton pump inhibitors are under a Class II recall for failing to meet dissolution specifications.
Prescription proton pump...
08/04/2022
Pharmacy Learning Network

Advertisement

News
Class I Recall for Diabetes Injection Pens
08/04/2022
Diabetes injection pens are under a Class I recall because some of the pens may be missing labels.
Diabetes injection pens are under a Class I recall because some of the pens may be missing labels.
Diabetes injection pens are...
08/04/2022
Pharmacy Learning Network
News
Emergency Injection Recalled
07/28/2022
A Class II recall has been issued for 153,445 syringes containing a prescription medicine used to treat life-threatening allergic reactions.
A Class II recall has been issued for 153,445 syringes containing a prescription medicine used to treat life-threatening allergic reactions.
A Class II recall has been...
07/28/2022
Pharmacy Learning Network
News
Analgesic Injections Recalled
07/28/2022
More than 50,000 syringes containing hydromorphone hydrochloride injection are under a Class II recall.
More than 50,000 syringes containing hydromorphone hydrochloride injection are under a Class II recall.
More than 50,000 syringes...
07/28/2022
Pharmacy Learning Network

Advertisement

News
IV Bags Recalled
07/28/2022
Nephron Sterile Compounding Center is voluntarily recalling intravenous bags containing fentanyl citrate injection.
Nephron Sterile Compounding Center is voluntarily recalling intravenous bags containing fentanyl citrate injection.
Nephron Sterile Compounding...
07/28/2022
Pharmacy Learning Network
News
To Stem the Spread of Monkeypox, Health Departments Tap Into Networks of Those Most at Risk
07/27/2022
Public health officials are working to control the transmission of monkeypox among vulnerable populations. 
Public health officials are working to control the transmission of monkeypox among vulnerable populations. 
Public health officials are...
07/27/2022
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use